 I'm Dom Savino with your Money Now. In a new report, federal regulators are accusing the country's medicine middlemen of steering patients away from less expensive medicines and overcharging them for cancer therapies, among other drugs. Nearly 95% of the prescriptions in the U.S. are handled by six so-called pharmacy benefit managers. They negotiate the terms for prescription drug access for most Americans.